<?xml-stylesheet type="text/xsl" href="http://localhost:8080/instahms/scripts/Monograph-Interaction-CDSDefault_withDuplicateAllergy.xsl" ?> 
<Result buildID="1914" copyright="Copyright (c) 2012 UBM Medica" expiryDate="2020-12-31"><Interaction><GGPI reference="{B3E6EDC8-2EB0-743D-E034-080020E1DD8C}" name="acetazolamide 250mg Oral Tablet" ><Route name="Systemic" reference="{90075601-10D4-49DD-9292-9B884D9D3EF3}"><HealthIssueCode code="I70.1" codeType="ICD10" name="Atherosclerosis of renal artery" ><ClassInteraction><PrescribingInteractionClass name="Acetazolamide" reference="{66D5ED76-05A5-4560-8503-8FB070D30C8A}" description="A carbonic anhydrase inhibitor with weak diuretic activity. "><PrescribingMolecule name="acetazolamide" reference="{48F34BC5-FF9B-488E-95CF-F1D0A4293E80}"/></PrescribingInteractionClass><Severity name="Contraindicated" ranking="3"></Severity><Likelihood name="Good" ranking="3">Good</Likelihood><Documentation name="Good" ranking="3">Good</Documentation><Interaction><Abbreviated>Acetazolamide may reduce the glomerular filtration rate, and is associated with acidosis in renal impairment. Contraindicated in severe renal impairment.</Abbreviated><Professional>Acetazolamide may reduce the glomerular filtration rate, and is associated with acidosis in renal impairment. Contraindicated in severe renal impairment.</Professional><Full></Full><Consumer></Consumer></Interaction></ClassInteraction></HealthIssueCode ></Route></GGPI><DuplicateTherapy></DuplicateTherapy></Interaction></Result>